PIPELINE

Developing 21st Century Medicines

SMDG is building a portfolio of therapeutic candidates for neurological diseases, rare pediatric diseases, inflammatory disorders and cancer. Our programs combine proprietary peptide-based technologies with advanced therapeutic payloads designed to reach disease-relevant tissues and cells and address underlying drivers of disease.

Built on Proprietary NanoLigand™ Technologies

SMDG’s pipeline is supported by its proprietary NanoLigand Carriers™ and NanoLigand Blocks™—peptide-based, non-viral technologies developed to enable targeted therapeutic delivery and biological intervention across multiple disease areas. This shared platform foundation allows SMDG to advance multiple programs while applying common expertise in therapeutic design, formulation, delivery and preclinical development.

Explore Our Science

Areas of Focus

Pipeline shows the different SMDG's different therapeutic areas.png

Partner With SMDG

SMDG welcomes discussions with pharmaceutical and biotechnology companies, academic and clinical researchers, patient organizations and investors interested in advancing new medicines for serious diseases.

Explore Partnerships